ILKAP and neoplasm: To investigate if ILKAP induces tumor resistance to CTL killing through a mechanism dependent on regulating IFN-γ or TNFα sensitivity, we stimulated ILKAP KO HCT 116 clone with IFN-γ or TNFα.